Fox, E. J., Markowitz, C., Applebee, A., Montalban, X., Wolinsky, J. S., Belachew, S., . . . Giovannoni, G. (2018). Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial. Mult Scler.
استشهاد بنمط شيكاغوFox, Edward J., et al. "Ocrelizumab Reduces Progression of Upper Extremity Impairment in Patients With Primary Progressive Multiple Sclerosis: Findings From the Phase III Randomized ORATORIO Trial." Mult Scler 2018.
MLA استشهادFox, Edward J., et al. "Ocrelizumab Reduces Progression of Upper Extremity Impairment in Patients With Primary Progressive Multiple Sclerosis: Findings From the Phase III Randomized ORATORIO Trial." Mult Scler 2018.